GlaxoSmithKline

WHO Calls for More Donation to Eradicate Neglected Tropical Diseases

As a consequence of World Health Organization’s call to donate medicines in the poorest countries to wipe out tropical diseases, GlaxoSmithKline on Thursday declared to donate an additional 400 million tablets to provide treatment to children suffering with intestinal worms.

Companies: 
General: 

Doors Close Down for Tyverb by GSK

The pharmaceutical Company GlaxoSmithKline has lost yet another battle for its oncology drug Tyverb. The National Institute for Health and Clinical Excellence has in fact issued new guidelines related to the use of the drug by the NHS for the breast cancer patients it is treating.

Companies: 
General: 

Herpes Vaccination by GSK Fails Trial

A vaccine meant to protect women from herpes has failed to clear trials in shielding them against the virus. The declaration regarding the failure of the vaccine was made by the U. S National Institute of Health.

The manufacturer of the medicine, GlaxoSmithKline has stalled the production of the vaccination. The trials were conducted on 8,000 women from the United States and Canada. Despite administering the anti-herpes vaccine Simplirix by GSK, the women fell prey to the virus and contracted genital herpes.

Companies: 
General: 

New F.D.A.: Transparence and Flexibility

A diabetes drug consumed by 100,000 Britons has been banned after complaining of the risk about the heart disease linked with it.

Avandia the drug was released to lower the blood sugar levels in case of patients having type 2 diabetes that strikes at middle and old age.

The European Medicines Agency proclaimed that the drug license has been snatched and no one can further prescribe it. Patients are advised to continue with the dosage of Avandia until another medicine is switched over.

General: 
Companies: 

Glaxo Going Through Losses After Avandia’s Scandal

As a result of the EMA’s decision to withdraw Avandia off the markets, GlaxoSmithKline has been experiencing losses day after day. As the market analysts gained the information regarding the fact that Avandia, the chief product of the giant pharmaceutical Company, GlaxoSmithKline, would no longer be the best selling diabetes drug in the world, they saw the fall coming.

General: 
Companies: 
Region: 

Pages

Subscribe to RSS - GlaxoSmithKline